Bulletin
Investor Alert

London Markets Open in:

Market Pulse Archives

July 13, 2020, 1:49 p.m. EDT

ElectroCore's stock rockets in active trading after EUA issued for its gammaCore Saphire CV

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    electroCore Inc. (ECOR)
  • X
    S&P 500 Index (SPX)

or Cancel Already have a watchlist? Log In

By Tomi Kilgore

Shares of electroCore Inc. /zigman2/quotes/204050944/composite ECOR +0.45% more than doubled (up 155%) on very heavy volume in afternoon trading Monday, after the bioelectronic medicine company said it was issued an emergency use authorization (EUA) by the Food and Drug Administration OK'ing the use of its gammaCore Sapphire CV to help in the treatment of COVID-19 patients. Trading volume soared to 136.7 million shares, enough to make the stock the most actively traded on the Nasdaq exchange, and compared with the full-day average of about 1.1 million shares. "Needless to say, we are very pleased to have received this EUA, and we intend work vigorously to make this novel therapy available to physicians treating known or suspected COVID 19 patients who are experiencing exacerbation of asthma-related breathing difficulty," said Chief Executive Dan Goldberger. The stock has rallied 36% year to date, while the S&P 500 /zigman2/quotes/210599714/realtime SPX +0.06% is little changed.

/zigman2/quotes/204050944/composite
US : U.S.: Nasdaq
$ 2.24
+0.01 +0.45%
Volume: 968,624
Aug. 7, 2020 4:00p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$85.41 million
Rev. per Employee
N/A
loading...
/zigman2/quotes/210599714/realtime
US : S&P US
3,351.28
+2.12 +0.06%
Volume: 2.28B
Aug. 7, 2020 5:10p
loading...

This Story has 0 Comments
Be the first to comment
More News In
Industries

Story Conversation

Commenting FAQs »
Link to MarketWatch's Slice.